GW842166X - 10mM in DMSO, high purity , CAS No.666260-75-9(DMSO), Cannabinoid CB2 receptor agonist

Item Number

G408958

• Synonyms: 2-(2,4-dichlorophenylamino)-N-((tetrahydro-2H-pyran-4-yl)methyl)-4-(trifluoromethyl)pyrimidine-5-carboxamide
• Specifications & Purity: 10mM in DMSO
• Biochemical and Physiological Mechanisms: GW842166X is a potent and highly selective agonist of cannabinoid receptor CB2 receptor with EC50 of 63 nM, shows no significant activity at CB1 receptor. Phase 2.
• Storage Temp: Store at -80°C
• Shipped In: Ice chest + Ice pads
• Action Type: AGONIST
• Mechanism of action: Cannabinoid CB2 receptor agonist

Product Description

Information

GW842166X is a potent and highly selective agonist ofcannabinoid receptor CB2receptor withEC50of 63 nM, shows no significant activity at CB1 receptor. Phase 2.
In vitro

GW842166X shows similar potency and efficacy for rat and human recombinant CB2 receptors with EC50 of 91 nM and 63nM, respectively. GW-842166X exhibits full agonist potency with an EC50 of 133 nM and E_max of 101% in cyclase assays. GW-842166X exhibits weak agonist potency with an EC50 of 7.780 μM and E_max of 84% in FLIPR assays.

In vivo

GW842166X has an oral bioavailability of 58% and a half-life of 3 h when dosed orally in the rat. GW842166X has extremely high potency with an oral ED50 of 0.1 mg/kg and shows full reversal of hyperalgesia at 0.3 mg/kg in the FCAa model of inflammatory pain. GW842166X orally administrated at a dose of 15 mg/kg for 8 days produced a significant reversal of the CCI induced decrease in paw withdrawal threshold in a rat model of neuropathic pain.
Cell Data

cell lines：SkBr3 cells

Concentrations：

Incubation Time：

Powder Purity:≥99%